HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
International Cancer Research Conference
March 24-26, 2025 | Singapore
Translational and Clinical Cancer Research
Translational and Clinical Cancer Research
- Liquid Biopsies and Biomarker Discovery
- Role of Artificial Intelligence in Cancer Diagnostics
- Innovative Clinical Trial Designs in Oncology
- Real-World Data and Evidence in Cancer Treatment
Translational and clinical cancer research plays a vital role in turning laboratory discoveries into real-world medical treatments. This field focuses on applying insights from basic science to develop novel therapies, aiming to enhance the quality of patient care. It encompasses the exploration of cancer mechanisms, the identification of potential biomarkers, and the testing of treatments through clinical trials. By bridging the gap between research and patient care, this approach fosters the creation of targeted therapies that are both innovative and personalized. As a result, translational and clinical research accelerates the delivery of cutting-edge cancer treatments to patients in need.
Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States Cancer Research 2025 Speakers
Patricia Tai
UpToDate, United States
Michele Mishto
Francis Crick Institute, United Kingdom
Farid Moinfar
Ordensklinikum Linz Barmherzige Schwestern, Austria
Paulo Cesar De Morais
Catholic University of Brasilia, BrazilSubmit your abstract Today
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title :
Sandrine Lacombe, University of Paris-Saclay, France
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : Molecular-genetic study of low-grade and high-grade “basal-like” (triple-negative) breast carcinomas
Farid Moinfar, Ordensklinikum Linz Barmherzige Schwestern, Austria
Title : Updates on cancer research for detection and management
Patricia Tai, UpToDate, United States
Title : Principles of oral rehabilitation in H&N cancer patients
Pietro Salvatori, Independent H&N Surgeon, Italy